Skip to main content
OpenTrials
Completed

NCT Number: NCT02118389

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure

Effect of Meal Replacement Beverage(Glucerna) on Body Composition,lipid metabolism and blood pressure

Completed

Looking for future studies?

Notify Me

Key information

Age range

14 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

The Effect of Meal Replacement Beverage(Glucerna) on Body Composition,lipid metabolism and blood pressure in Patients with Obesity

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age:14~60years
  • BMI ≥ 28kg/m2
  • without liver, kidney, gastrointestinal and other major organic serious diseases,lactating women, pregnancy

Treatment and study plan

Glucerna

Dietary Supplement

Glucerna 52g meal replacement

Other names: Glucerna (Abbort,SR)

Primary outcomes

  1. Dual energy X-ray absorptiometry

    Time frame: 5 weeks

Secondary outcomes

  1. lab testing

    Time frame: 5weeks

Other outcomes

  1. blood pressure

    Time frame: 5 weeks

Sponsors and collaborators

Lead sponsor

Shanghai 10th People's Hospital

Other

Registry information

Official study title

The Effect of Meal Replacement Beverage(Glucerna) on Body Composition,Lipid Metabolism and Blood Pressure in Patients With Obesity

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Apr 21, 2014
Registry last updated
Apr 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.